4
Changes in Ownership
Cytosorbents Corp Filed Acc 0001144204-18-042396
Chief Financial Officer sold 10,000 shares at an average $12.54 ($125,364)
- Chief Financial Officer acquired 10,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BLOCH KATHLEEN P. Chief Financial Officer | 2018-08-03 | Option exercise | +10,000 | $2.88 | $28,750 | 260,004 | D |
| BLOCH KATHLEEN P. Chief Financial Officer | 2018-08-03 | Sale | −200 | $12.85 | $2,570 | 259,804 | D |
| BLOCH KATHLEEN P. Chief Financial Officer | 2018-08-03 | Sale | −6,200 | $12.75 | $79,050 | 253,604 | D |
| BLOCH KATHLEEN P. Chief Financial Officer | 2018-08-03 | Sale | −3,600 | $12.15 | $43,744 | 250,004 | D |
| Derivatives | |||||||
| BLOCH KATHLEEN P. Chief Financial Officer | 2018-08-03 | Option exercise · Stock Option (Right to Buy) | −10,000 | 10,000 | D | ||
| Open-market sales · 10,000 sh · avg $12.54 · $125,364 | |||||||
Loading xslF345X03/tv500351_4.xml…